Skip to content
Gamora Portal

The Zimbabwean Government Turns Down ‘Lopsided’ US Healthcare Assistance Deal Due to Information Fears

Medical aid illustration
The proposed US funding was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has declined a major US healthcare agreement valued at $367m (£272m) spanning five years because of Washington's request for confidential biological samples.

This rejection became public following a internal memorandum from December was disclosed, indicating that President Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesperson later clarified that the US was demanding access to health data for research and profit but was not willing to guarantee the resulting advantages from any future vaccines.

"We are forced to start the difficult and regrettable task of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has called for continued talks to find a deal agreeable to both sides so the country's vital HIV programme can continue.

Wider Context

This rejection comes after a comparable situation in neighbouring Kenya, where a court blocked a related deal with the US following concerns were filed about the security of citizens' health data.

After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

USAID had overseen assistance for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and accountability.

Based on reports, Sixteen African countries have so far signed these new agreements, representing over $18.3bn of fresh investment.

Details of the Rejected Deal

This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," the Ambassador said.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that shared data," Mangwana explained.

"Put simply, our country would provide the raw materials for scientific discovery without any assurance that the end products would be accessible to our citizens should a new disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting structures already set up through the international organization.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.

"This system is intended to ensure that when a nation contributes its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We welcome ongoing dialogue with our American counterparts on how subsequent co-operation might be arranged in a way that honours the sovereignty and interests of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but recommended that negotiations must proceed since much of the country's Aids initiatives were funded by external financing.

"If technical issues arise, including those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," it said.

This impasse emphasises the ongoing challenges between accepting much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.

SV
The writer

Steven Velasquez

A passionate gaming journalist with over a decade of experience covering UK and international gaming scenes, specializing in indie games and industry analysis.

Gamora Portal

Type to search articles.